Global Artificial Heart and Ventricular Assist Devices Market Size, Share, Trends and Forecast 2020-2026

Description

the global Artificial Heart and Ventricular Assist Devices market has been provided based on region.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Artificial Heart and Ventricular Assist Devices market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of volume for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Artificial Heart and Ventricular Assist Devices market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Artificial Heart and Ventricular Assist Devices market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Artificial Heart and Ventricular Assist Devices market.
The following manufacturers are covered in this report:
SynCardia Systems
Medtronic PLC
Abbott Laboratories
BiVACOR
Berlin Heart
ABIOMED
LivaNova PLC
CARMAT
Jarvik Heart Inc
Chongqing Yongrenxin Medical
Thoratec
Cleveland Heart
CryoLife
Artificial Heart and Ventricular Assist Devices Breakdown Data by Type
Artificial Heart
Ventricular Assist Devices
Artificial Heart and Ventricular Assist Devices Breakdown Data by Application
Coronary Heart Disease
Cerebrovascular Disease
Peripheral Arterial Disease
Rheumatic Heart Disease
Congenital Heart Disease
Deep Vein Thrombosis
Other

TABLE OF CONTENT

1 Study Coverage
1.1 Artificial Heart and Ventricular Assist Devices Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Artificial Heart and Ventricular Assist Devices Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Artificial Heart and Ventricular Assist Devices Market Size Growth Rate by Type
1.4.2 Artificial Heart
1.4.3 Ventricular Assist Devices
1.5 Market by Application
1.5.1 Global Artificial Heart and Ventricular Assist Devices Market Size Growth Rate by Application
1.5.2 Coronary Heart Disease
1.5.3 Cerebrovascular Disease
1.5.4 Peripheral Arterial Disease
1.5.5 Rheumatic Heart Disease
1.5.6 Congenital Heart Disease
1.5.7 Deep Vein Thrombosis
1.5.8 Other
1.6 Coronavirus Disease 2019 (Covid-19): Artificial Heart and Ventricular Assist Devices Industry Impact
1.6.1 How the Covid-19 is Affecting the Artificial Heart and Ventricular Assist Devices Industry
1.6.1.1 Artificial Heart and Ventricular Assist Devices Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Artificial Heart and Ventricular Assist Devices Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Artificial Heart and Ventricular Assist Devices Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Artificial Heart and Ventricular Assist Devices Market Size Estimates and Forecasts
2.1.1 Global Artificial Heart and Ventricular Assist Devices Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Artificial Heart and Ventricular Assist Devices Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Artificial Heart and Ventricular Assist Devices Production Estimates and Forecasts 2015-2026
2.2 Global Artificial Heart and Ventricular Assist Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Artificial Heart and Ventricular Assist Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Artificial Heart and Ventricular Assist Devices Manufacturers Geographical Distribution
2.4 Key Trends for Artificial Heart and Ventricular Assist Devices Markets & Products
2.5 Primary Interviews with Key Artificial Heart and Ventricular Assist Devices Players (Opinion Leaders)

3 Market Size by Manufacturers
3.1 Global Top Artificial Heart and Ventricular Assist Devices Manufacturers by Production Capacity
3.1.1 Global Top Artificial Heart and Ventricular Assist Devices Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Artificial Heart and Ventricular Assist Devices Manufacturers by Production (2015-2020)
3.1.3 Global Top Artificial Heart and Ventricular Assist Devices Manufacturers Market Share by Production
3.2 Global Top Artificial Heart and Ventricular Assist Devices Manufacturers by Revenue
3.2.1 Global Top Artificial Heart and Ventricular Assist Devices Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Artificial Heart and Ventricular Assist Devices Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Artificial Heart and Ventricular Assist Devices Revenue in 2019
3.3 Global Artificial Heart and Ventricular Assist Devices Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans

4 Artificial Heart and Ventricular Assist Devices Production by Regions
4.1 Global Artificial Heart and Ventricular Assist Devices Historic Market Facts & Figures by Regions
4.1.1 Global Top Artificial Heart and Ventricular Assist Devices Regions by Production (2015-2020)
4.1.2 Global Top Artificial Heart and Ventricular Assist Devices Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Artificial Heart and Ventricular Assist Devices Production (2015-2020)
4.2.2 North America Artificial Heart and Ventricular Assist Devices Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Artificial Heart and Ventricular Assist Devices Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Artificial Heart and Ventricular Assist Devices Production (2015-2020)
4.3.2 Europe Artificial Heart and Ventricular Assist Devices Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Artificial Heart and Ventricular Assist Devices Import & Export (2015-2020)
4.4 China
4.4.1 China Artificial Heart and Ventricular Assist Devices Production (2015-2020)
4.4.2 China Artificial Heart and Ventricular Assist Devices Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Artificial Heart and Ventricular Assist Devices Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Artificial Heart and Ventricular Assist Devices Production (2015-2020)
4.5.2 Japan Artificial Heart and Ventricular Assist Devices Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Artificial Heart and Ventricular Assist Devices Import & Export (2015-2020)

5 Artificial Heart and Ventricular Assist Devices Consumption by Region
5.1 Global Top Artificial Heart and Ventricular Assist Devices Regions by Consumption
5.1.1 Global Top Artificial Heart and Ventricular Assist Devices Regions by Consumption (2015-2020)
5.1.2 Global Top Artificial Heart and Ventricular Assist Devices Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Artificial Heart and Ventricular Assist Devices Consumption by Application
5.2.2 North America Artificial Heart and Ventricular Assist Devices Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Artificial Heart and Ventricular Assist Devices Consumption by Application
5.3.2 Europe Artificial Heart and Ventricular Assist Devices Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Artificial Heart and Ventricular Assist Devices Consumption by Application
5.4.2 Asia Pacific Artificial Heart and Ventricular Assist Devices Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Artificial Heart and Ventricular Assist Devices Consumption by Application
5.5.2 Central & South America Artificial Heart and Ventricular Assist Devices Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Artificial Heart and Ventricular Assist Devices Consumption by Application
5.6.2 Middle East and Africa Artificial Heart and Ventricular Assist Devices Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E

6 Market Size by Type (2015-2026)
6.1 Global Artificial Heart and Ventricular Assist Devices Market Size by Type (2015-2020)
6.1.1 Global Artificial Heart and Ventricular Assist Devices Production by Type (2015-2020)
6.1.2 Global Artificial Heart and Ventricular Assist Devices Revenue by Type (2015-2020)
6.1.3 Artificial Heart and Ventricular Assist Devices Price by Type (2015-2020)
6.2 Global Artificial Heart and Ventricular Assist Devices Market Forecast by Type (2021-2026)
6.2.1 Global Artificial Heart and Ventricular Assist Devices Production Forecast by Type (2021-2026)
6.2.2 Global Artificial Heart and Ventricular Assist Devices Revenue Forecast by Type (2021-2026)
6.2.3 Global Artificial Heart and Ventricular Assist Devices Price Forecast by Type (2021-2026)
6.3 Global Artificial Heart and Ventricular Assist Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)
7.2.1 Global Artificial Heart and Ventricular Assist Devices Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Artificial Heart and Ventricular Assist Devices Consumption Forecast by Application (2021-2026)

8 Corporate Profiles
8.1 SynCardia Systems
8.1.1 SynCardia Systems Corporation Information
8.1.2 SynCardia Systems Overview and Its Total Revenue
8.1.3 SynCardia Systems Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 SynCardia Systems Product Description
8.1.5 SynCardia Systems Recent Development
8.2 Medtronic PLC
8.2.1 Medtronic PLC Corporation Information
8.2.2 Medtronic PLC Overview and Its Total Revenue
8.2.3 Medtronic PLC Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Medtronic PLC Product Description
8.2.5 Medtronic PLC Recent Development
8.3 Abbott Laboratories
8.3.1 Abbott Laboratories Corporation Information
8.3.2 Abbott Laboratories Overview and Its Total Revenue
8.3.3 Abbott Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Abbott Laboratories Product Description
8.3.5 Abbott Laboratories Recent Development
8.4 BiVACOR
8.4.1 BiVACOR Corporation Information
8.4.2 BiVACOR Overview and Its Total Revenue
8.4.3 BiVACOR Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 BiVACOR Product Description
8.4.5 BiVACOR Recent Development
8.5 Berlin Heart
8.5.1 Berlin Heart Corporation Information
8.5.2 Berlin Heart Overview and Its Total Revenue
8.5.3 Berlin Heart Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Berlin Heart Product Description
8.5.5 Berlin Heart Recent Development
8.6 ABIOMED
8.6.1 ABIOMED Corporation Information
8.6.2 ABIOMED Overview and Its Total Revenue
8.6.3 ABIOMED Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 ABIOMED Product Description
8.6.5 ABIOMED Recent Development
8.7 LivaNova PLC
8.7.1 LivaNova PLC Corporation Information
8.7.2 LivaNova PLC Overview and Its Total Revenue
8.7.3 LivaNova PLC Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 LivaNova PLC Product Description
8.7.5 LivaNova PLC Recent Development
8.8 CARMAT
8.8.1 CARMAT Corporation Information
8.8.2 CARMAT Overview and Its Total Revenue
8.8.3 CARMAT Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 CARMAT Product Description
8.8.5 CARMAT Recent Development
8.9 Jarvik Heart Inc
8.9.1 Jarvik Heart Inc Corporation Information
8.9.2 Jarvik Heart Inc Overview and Its Total Revenue
8.9.3 Jarvik Heart Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Jarvik Heart Inc Product Description
8.9.5 Jarvik Heart Inc Recent Development
8.10 Chongqing Yongrenxin Medical
8.10.1 Chongqing Yongrenxin Medical Corporation Information
8.10.2 Chongqing Yongrenxin Medical Overview and Its Total Revenue
8.10.3 Chongqing Yongrenxin Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Chongqing Yongrenxin Medical Product Description
8.10.5 Chongqing Yongrenxin Medical Recent Development
8.11 Thoratec
8.11.1 Thoratec Corporation Information
8.11.2 Thoratec Overview and Its Total Revenue
8.11.3 Thoratec Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Thoratec Product Description
8.11.5 Thoratec Recent Development
8.12 Cleveland Heart
8.12.1 Cleveland Heart Corporation Information
8.12.2 Cleveland Heart Overview and Its Total Revenue
8.12.3 Cleveland Heart Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Cleveland Heart Product Description
8.12.5 Cleveland Heart Recent Development
8.13 CryoLife
8.13.1 CryoLife Corporation Information
8.13.2 CryoLife Overview and Its Total Revenue
8.13.3 CryoLife Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 CryoLife Product Description
8.13.5 CryoLife Recent Development

9 Production Forecasts by Regions
9.1 Global Top Artificial Heart and Ventricular Assist Devices Regions Forecast by Revenue (2021-2026)
9.2 Global Top Artificial Heart and Ventricular Assist Devices Regions Forecast by Production (2021-2026)
9.3 Key Artificial Heart and Ventricular Assist Devices Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan

10 Artificial Heart and Ventricular Assist Devices Consumption Forecast by Region
10.1 Global Artificial Heart and Ventricular Assist Devices Consumption Forecast by Region (2021-2026)
10.2 North America Artificial Heart and Ventricular Assist Devices Consumption Forecast by Region (2021-2026)
10.3 Europe Artificial Heart and Ventricular Assist Devices Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Artificial Heart and Ventricular Assist Devices Consumption Forecast by Region (2021-2026)
10.5 Latin America Artificial Heart and Ventricular Assist Devices Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Artificial Heart and Ventricular Assist Devices Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Artificial Heart and Ventricular Assist Devices Sales Channels
11.2.2 Artificial Heart and Ventricular Assist Devices Distributors
11.3 Artificial Heart and Ventricular Assist Devices Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 Key Finding in The Global Artificial Heart and Ventricular Assist Devices Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample